Immunogenicity and reactogenicity of repeated intradermal mRNA COVID-19 vaccines administered as a second booster dose in a Thai geriatric population
BackgroundGeriatric populations are at an increased risk of severe presentations, hospitalization, and loss of life from COVID-19. Few studies have explored vaccination regimens in adults >65 years old. Repeated booster vaccination is required for high-risk populations as COVID-19 vaccine eff...
Main Authors: | Prasert Assantachai, Suvimol Niyomnaitham, Zheng Quan Toh, Monthira Thammasalee, Napaporn Pengsorn, Wiyachatr Monklang, Paul V. Licciardi, Kulkanya Chokephaibulkit |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1302041/full |
Similar Items
-
Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations
by: Suvimol Niyomnaitham, et al.
Published: (2023-01-01) -
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
by: Somruedee Chatsiricharoenkul, et al.
Published: (2022-10-01) -
Evaluation of the Safety and Immunogenicity of Fractional Intradermal COVID-19 Vaccines as a Booster: A Pilot Study
by: Suvimol Niyomnaitham, et al.
Published: (2022-09-01) -
Immunogenicity of BNT162b2 as a first booster after a ChAdOx1 primary series in a Thai geriatric population living with frailty
by: Suvimol Niyomnaitham, et al.
Published: (2024-08-01) -
Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
by: Suvimol Niyomnaitham, et al.
Published: (2022-11-01)